ORGAN-PRESERVING TREATMENT IN GYNECOLOGICAL TYPES OF CANCER

Abstract

Over the past 10 years, the treatment of malignant gynecological tumors has changed dramatically. For many years, a radical approach - extended hysterectomy with appendages at any stage of tumor development of internal genital organs was considered to be the only correct approach. However, many young women want to preserve their fertile function, and in this regard, the treatment tactic was improved and optimized towards the development of organ-preserving methods for the treatment of gynecological cancer. Based on the literature studied from the MedLine database, an analytical review of information on the possibilities of organ-preserving treatment for gynecological cancers in 2013-2018 was prepared and the implementation of a successful integrated organ-preserving treatment was found to be available only at early stages of cervical, endometrial and ovarian cancer. The overall survival after treatment correlates with the histological structure of the tumor, the degree of its differentiation and involvement of the underlying tissues in the pathological process, as well as the volume of surgical intervention. In most cases, after an organ-preserving treatment, the risk of tumor recurrence is low, and a woman regains a chance to become pregnant and give birth to a healthy child.

Keywords

review / organ preservation treatment / gynecological cancer / cervical cancer / ovarian cancer / endometrial cancer / relapse / pregnancy

References

[1] De Felice F., Marchetti C., Di Pinto A., Musella A., Palaia I., Grazia Porpora M., et al. Fertility preservation in gynaecologic cancers. Ecancermedicalscience. 2018; 12: 798. https://doi.org/10.3332/ecancer.2018.798

[2] Carneiro M.M., Lamaita R.M., Ferreira M.C.F., Silva-Filho A.L. Fertility-preservation in endometrial cancer: is it safe? Review of the literature. JBRA Assist Reprod. 2016; 20(4): 232-9. doi: 10.5935/1518-0557.20160045

[3] Радзинский В.Е., Фукс А.М. Гинекология: учебник. М.: ГЭОТАР- Медиа; 2014

[4] Park J.Y., Nam J.H. Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer. Oncologist. 2015; 20(3): 270-8. doi: 10.1634/theoncologist.2013-0445

[5] Rockall A.G., Qureshi M., Papadopoulou I., Saso S., Butterfield N., Thomassin-Naggara I. et al. Role of imaging in fertility-sparing treatment of gynecologic malignancies. Radiographics. 2016; 36(7): 2214-33.

[6] Giampaolino P., Di Spiezio Sardo A., Mollo A., Raffone A., Travaglino A., Boccellino A., et al. Hysteroscopic Endometrial focal resection followed by Levonorgestrel intrauterine device insertion as a fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial cancer: a retrospective study. J. Minim. Invasive Gynecol. 2018; doi: 10.1016/j.jmig.2018.07.001

[7] Нечушкина В.М., Деньгина Н.В., Коломиец Л.А., Кравец О.А., Морхов К.Ю., Новикова Е.Г. и др. Практические рекомендации по лекарственному лечению рака тела матки и сарком матки. Злокачественные опухоли. 2017; 7(3-S2): 168-80. DOI: 10.18027/2224-5057-2017-7-3s2-l68-l80

[8] Parlakgumus H.A., Kilicdag E.B., Simsek E., Haydardedeoglu B., Cok T., Aytac P.C., Bagis T., Erkanlı S. Fertility outcomes of patients with early stage endometrial carcinoma. J. Obstet. Gynaecol. Res. 2014; 40(1):102-8. doi: 10.1111/jog.12132

[9] Fan Z., Li H., Hu R., Liu Y., Liu X., Gu L. Fertility-preserving treatment in young women with grade 1 presumed stage ia endometrial adenocarcinoma: a meta-analysis. Int. J. Gynecol. Cancer. 2018; 28(2): 385-93. doi: 10.1097/IGC.0000000000001164

[10] Martinez A., Poilblanc M., Ferron G., De Cuypere M., Jouve E., Querleu D. Fertility-preserving surgical procedures, techniques. Best Pract. Res. Clin. Obstet. Gynaecol. 2012; 26(3): 407-24. doi:10.1016/j.bpobgyn.2012.01.009

[11] Feichtinger M., Rodriguez-Wallberg K.A. Fertility preservation in women with cervical, endometrial or ovarian cancers. Gynecol. Oncol. Res. Pract. 2016; 3: 8. doi: 10.1186/s40661-016-0029-2

[12] Хохлова С.В., Деньгина Н.В., Коломиец Л.А., Кравец О.А., Морхов К.Ю., Нечушкина В.М. и др. Практические рекомендации по лекарственному лечению рака шейки матки. Злокачественные опухоли. 2017; 7(3-S2): 158-67. DOI: 10.18027/2224-5057-20l7-7-3s2-l58-l67

[13] Willows K., Lennox G., Covens A. Fertility-sparing management in cervical cancer: balancing oncologic outcomes with reproductive success. Gynecol. Oncol. Res. Pract. 2016; 3: 9. eCollection 2016.

[14] Gabriele V., Lecointre L., Faller E., Akladios C. Type B laparoscopic radical trachelectomy with uterine artery preservation for stage IB1 cervical cancer. J. Minim. Invasive Gynecol. 2018; pii: S1553-4650(18)30260-7. doi: 10.1016/j.jmig.2018.05.006

[15] Demirkiran F., Kahramanoglu I., Bese T., Turan H., Meseci E., Arvas M. Simple vaginal trachelectomy for early stage cervical cancer: A tertiary cancer center experience. Ginekol. Pol. 2018; 89(9): 475-80. doi: 10.5603/GP.a2018.0081

[16] Olav Istre, ed. Minimally Invasive Gynecological Surgery. Springer Heidelberg, New York, Dordrecht, London; 2015. DOI 10.1007/978-3-662-44059-9

[17] Smith J.R., Del Priore G., J.P. Curtin, Monaghan J.M. Atlas of Gynecologic Oncology. London, New York: Taylor & Francis; 2005.

[18] Wu P.Y., Cheng Y.M., New G.H., Chou C.Y., Chiang C.T., Tsai H.W., Huang Y.F. Case report: term birth after fertility-sparing treatments for stage IB1 small cell neuroendocrine carcinoma of the cervix. BMC Womens Health. 2017; 17(1):56. doi:10.1186/s12905-017-0404-0.

[19] Тюляндин С.А., Коломиец Л.А., Морхов К.Ю., Нечушкина В.М., Покатаев И.А., Тюляндина А.С. и др. Практические рекомендации по лекарственному лечению рака яичников, первичного рака брюшины и рака маточных труб. Злокачественные опухоли. 2017; 7(3-S2): 135-45. DOI: 10.18027/2224-5057-2017-7-3s2-135-145

[20] Vancraeynest E., Moerman P., Leunen K., Amant F., Neven P., Vergote I. Fertility preservation is safe for serous borderline ovarian tumors. Int. J. Gynecol. Cancer. 2016; 26(8):1399-406. doi: 10.1097/IGC.0000000000000782

[21] Chen R.F., Li J., Zhu T.T., Yu H.L., Lu X. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience. J. Ovarian Res. 2016; 9:16. doi: 10.1186/s13048-016-0226-y

[22] Ditto A., Martinelli F., Lorusso D., Haeusler E., Carcangiu M., Raspagliesi F. Fertility sparing surgery in early stage epithelial ovarian cancer. J. Gynecol. Oncol. 2014; 25(4):320-7. doi: 10.3802/jgo.2014.25.4.320

[23] Kim S., Lee Y., Lee S., Kim T. Ovarian tissue cryopreservation and transplantation in patients with cancer. Obstet. Gynecol. Sci. 2018; 61(4):431-442. doi: 10.5468/ogs.2018.61.4.431

[24] Beckmann M.W., Dittrich R., Findeklee S., Lotz L. Surgical aspects of ovarian tissue removal and ovarian tissue transplantation for fertility preservation. Geburtshilfe Frauenheilkd. 2016; 76(10): 1057-64.

RIGHTS & PERMISSIONS

Eco-Vector